{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:09:32Z","timestamp":1761563372632,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.carrev.2021.04.014","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T03:13:54Z","timestamp":1618802034000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"35","author":[{"given":"Hui Wen","family":"Sim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H.","family":"Thong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andie H.","family":"Djohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Sin","family":"Ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poay Huan","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian F.","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar L.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koo Hui","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huay Cheem","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.04.014_bb0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacc.2007.04.059","article-title":"Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden","volume":"50","author":"Sianos","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.04.014_bb0010","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.04.014_bb0015","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.04.014_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2014.04.022","article-title":"Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR","volume":"64","author":"Sarno","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.carrev.2021.04.014_bb0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jcin.2008.11.015","article-title":"Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer","volume":"2","author":"Byrne","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/erc.12.29","article-title":"No country for old stents? Improving long-term patient outcomes with biodegradable polymer drug-eluting stents","volume":"10","author":"Byrne","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"Suppl F","key":"10.1016\/j.carrev.2021.04.014_bb0035","doi-asserted-by":"crossref","first-page":"F28","DOI":"10.4244\/EIJV5IFA5","article-title":"The bioabsorption process: tissue and cellular mechanisms and outcomes","volume":"5","author":"Vorpahl","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.04.014_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCINTERVENTIONS.113.001440","article-title":"Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction two-year clinical results of the COMFORTABLE AMI trial","volume":"7","author":"R\u00e4ber","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4244\/EIJV10I12A247","article-title":"Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials","volume":"10","author":"de Waha","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.04.014_bb0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jcin.2016.12.002","article-title":"Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents","volume":"10","author":"El-Hayek","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.04.014_bb0060","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4244\/EIJ-D-17-01087","article-title":"Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study","volume":"14","author":"Valdes-Chavarri","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.04.014_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008152","article-title":"Clinical outcomes following implantation of thin-strut, bioabsorbable polymer-coated, everolimus-eluting SYNERGY stents","volume":"12","author":"Kereiakes","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0070","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.04.014_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4244\/EIJV11I3A53","article-title":"Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluti)","volume":"11","author":"Vlachojannis","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.04.014_bb0080","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.4244\/EIJ-D-19-00865","article-title":"Biodegradable polymer- versus durable polymer-coated Sirolimus-eluting stents: the final 5-year outcomes of the I-LOVE-IT 2 trial","volume":"16","author":"Xu","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2021.04.014_bb0085","first-page":"347","article-title":"Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction","volume":"14","author":"G\u0105sior","year":"2018","journal-title":"Postep w Kardiol Interwencyjnej"},{"key":"10.1016\/j.carrev.2021.04.014_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2019.02.022","article-title":"One-year clinical outcomes between biodegradable-polymer-coated biolimus-eluting stent and durable-polymer-coated drug-eluting stents in STEMI patients with multivessel coronary artery disease undergoing culprit-only or multivessel PCI","volume":"284","author":"Kim","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2021.04.014_bb0095","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.04.014_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jcin.2019.08.020","article-title":"Korea acute myocardial infarction registry-National Institutes of Health Investigators. Long-term outcomes of biodegradable versus second-generation durable polymer drug-eluting stent implantations for myocardial infarction","volume":"13","author":"Choe","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0105","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.04.014_bb0110","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003803","article-title":"Comparison of vascular responses following new-generation biodegradable and durable polymer-based drug-eluting stent implantation in an atherosclerotic rabbit iliac artery model","volume":"5","author":"Nakazawa","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2021.04.014_bb0115","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jcin.2019.04.054","article-title":"Thin, very thin, or ultrathin strut biodegradable or durable polymer-coated drug-eluting stents: 3-year outcomes of BIO-RESORT","volume":"12","author":"Buiten","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2021.04.014_bb0120","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2021.04.014_bb0125","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/ehjci\/jex334","article-title":"Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials","volume":"19","author":"Cassese","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2021.04.014_bb0130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2021.04.014_bb0135","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2021.04.014_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jamacardio.2019.4852","article-title":"Safety and efficacy of femoral access vs radial access in ST-segment elevation myocardial infarction: the SAFARI-STEMI randomized clinical trial","volume":"5","author":"Le May","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:23:31Z","timestamp":1761560611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":28,"alternative-id":["S1553838921002025"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.04.014","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}